Overview

LF

ONC

LOA

SCH

STH

TH

WaSH

Introduction
Drug packages
Coendemicity
JAP search
Demographics

National summary statistics for

Endemic NTDs requiring PC
Lymphatic filariasis
Onchocerciasis
STH
Schistosomiasis
NTDs targeted with PC
STH
Schistosomiasis

Demographics

164
Number of implementation units (IUs)
32,064,304
Total Population
5,130,287
Total PreSAC Population
8,945,937
Total SAC Population
16,897,885
Total Adult Population

Programme status*

1,228,217people
3IUs
Population living in IUs with endemicity unknown for at least one PC-NTD
14,443,870people
159IUs
Population requiring PC for at least one PC-NTD
0people
0IUs
Population living in IUs that have stopped PC for at least one PC-NTD

Delivery of PC in 2021*

4,402,622people
90IUs
Population targeted with PC for at least one NTD
2,735,395people
90IUs
Population treated with PC for at least one NTD
11 IUs (7% of all endemic IUs)
IUs achieving effective coverage for all NTDs requiring PC

Reporting

Most recent approved JRF
2022
Most recent approved JRSM
2023
*These statistics exclude trachoma, as data are currently reporting using alternative implementation unit information, making integration unfeasible

Looking forwards

Forecast activities in alignment with the 2021-2030 WHO NTD Roadmap. See here for further detail on assumptions

16,577,191treatments to be delivered
102IUs to be surveyed
2020 to 2022
70,327,199treatments to be delivered
169IUs to be surveyed
2023 to 2025
127,002,093treatments to be delivered
284IUs to be surveyed
2026 to 2030
For further details of ESPEN forecasts by disease, please refer to the ‘Forecast dashboard’ under each disease tab.

Data source

Unless otherwise stated, all programmatic and epidemiological data underlying these dashboards are provided by countries to ESPEN through WHO reporting processes, including via the PC Joint Application Package. All reasonable precautions have been taken to verify this information.

Country health information platform

Access the CHIP country dashboard.

View dashboard

Lymphatic filariasis

Progress dashboard
Forecast dashboard
Maps
Data

Key statistics for

Population living in IUs requiring PC: 4,105,407 people | 38 IUs
Population living in IUs that have stopped PC: 0 people | 0 IUs
Population targeted for PC: 0 people | 0 IUs in total
Population treated with PC: 0 people | 0 IUs in total
0 IUs achieved effective coverage
Drug regimen: No PC reported
Coverage indicators
Geographic coverage: 0% of endemic IUs covered by PC
Programme coverage: 0% of individuals living in targeted IUs were treated
National coverage: 0% of individuals requiring PC in the country were treated
Please click on an Implementation Unit to view the PC coverage/year

Onchocerciasis

Progress dashboard
Forecast dashboard
Maps
Data

Key statistics for

Population living in IUs requiring PC: 6,430,925 people | 48 IUs
Population living in IUs that have stopped PC: 0 people | 0 IUs
Population targeted for PC: 0 people | 0 IUs in total
Population treated with PC: 0 people | 0 IUs in total
0 IUs achieved effective coverage
Drug regimen: No PC reported
Coverage indicators
Geographic coverage: 0% of endemic IUs covered by PC
Programme coverage: 0% of individuals living in targeted IUs were treated
National coverage: 0% of individuals requiring PC in the country were treated
Please click on an Implementation Unit to view the PC coverage/year

Loiasis

Maps
Data

Mapping Surveys

27590

https://espen.afro.who.int/system/files/content/data/legends/Loiasis_SiteLevel_DataSources_Legend_0.xlsx
Site Level maps
Year(s) Type Portrait maps Landscape maps Data
2003 - 2011 EWH-Questionnaire Download map png Download map pdf

Endemicity

27588

https://espen.afro.who.int/system/files/content/data/legends/Loiasis_IU_DataSources_Legend_0.xlsx
IU maps
Year(s) Portrait maps Landscape maps Data
2015 Download map png Download map pdf Download map png Download map pdf

Schistosomiasis

Progress dashboard
Forecast dashboard
Maps
Data

Key statistics for

Population living in IUs requiring PC: 3,399,616 SAC | 1,888,816 adults
138 IUs in total | 3 IUs high prevalence & 77 IUs moderate prevalence & 58 IUs low prevalence
Population targeted for PC: 1,343,364 SAC | 0 Adults
26 IUs targeted
Population treated with PC: 989,662 SAC | 0 Adults
12 IUs achieved effective coverage
Drug regimen: PZQ in 11 IUs PZQ+ALB/MBD in 15 IUs
Coverage indicators
Geographic coverage: 26% of IUs requiring PC
Programme coverage: 74% of SAC and 0% of Adults targeted for PC were treated
National coverage: 29% of SAC and 0% of Adults requiring PC in the country were treated
Please click on an Implementation Unit to view the PC coverage/year